Market Place
Sourcing Support
Strategic Investments to Meet the Growing Demand for Sterile
12 Nov 2024 //
PRESS RELEASE
Our next beauty 2024 exhibitions
13 Aug 2024 //
PRESS RELEASE
Fareva, ApiJect Sign 10-Year Blow-Fill-Seal Licensing Agreement
10 Dec 2021 //
PRNEWSWIRE
Fareva and ApiJect Sign a Licensing Agreement
10 Dec 2021 //
PRESS RELEASE
Fareva Excella increases its production capacities of highly active products
11 May 2021 //
PRESS RELEASE
Fareva takes over Novartis location with Wolf Theiss
28 Apr 2021 //
EXTRAJOURNALS
Fareva to grow its newly acquired biomanufacturing capabilities
20 Apr 2021 //
BIOPROCESSINTL
France ramps up COVID-19 vaccine production
10 Feb 2021 //
BIOPHARMAREPORTER
Fareva’s Acquisition of Mirabel production site
04 Feb 2021 //
GLOBALLEGALCHRONICLE
MSD completes the sale of its Mirabel production site to the pharmaceutical group FAREVA
18 Jan 2021 //
PRESS RELEASE
Bayer joins Wacker and Fareva in CureVac’s COVID-19 vaccine network
08 Jan 2021 //
BIOPROCESSINTL
CureVac & Fareva agreement for fill & finish manufacturing of CureVac’s COVID
09 Dec 2020 //
PRESS RELEASE
Fareva strengthens its position in sterile development and manufacturing
01 Dec 2020 //
PRESS RELEASE
Fareva strengthens its position in the sterile field
26 Nov 2020 //
PRESS RELEASE
French CMO Fareva adds 4 facilities, more than 1,000 employees
10 Nov 2020 //
FIERCE PHARMA
Fareva Expands Sterile Production Capabilities
06 Nov 2020 //
CONTRACTPHARMA
Chromavis appoints Thibaut Fraisse as new CEO
08 Oct 2020 //
PREMIUMBEAUTYNEWS
CureVac and Fareva Sign Agreement for Filling and Packaging of CureVac`s COVID19 Vaccine Candidate
12 Sep 2020 //
PRESS RELEASE
Fareva is one of the world leaders in pharma subcontracting sterile products.
09 Jul 2020 //
PRESS RELEASE
LATAM R&D to strengthen development capabilities with new lab
19 Feb 2020 //
PRESS RELEASE
Axyntis, independent, multi-site leader in the strategic sector of fine chemicals in France
27 Mar 2017 //
PRESS RELEASE
Fareva buys Merck & Co API plant in France and outlines plan to invest €25m
01 Sep 2015 //
IN-PHARMA TECHNOLOGIST
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.